KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Operating Expenses (2017 - 2025)

Twist Bioscience (TWST) has disclosed Operating Expenses for 9 consecutive years, with $136.6 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 10.73% to $136.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $526.1 million through Dec 2025, down 2.34% year-over-year, with the annual reading at $512.8 million for FY2025, 3.93% down from the prior year.
  • Operating Expenses for Q4 2025 was $136.6 million at Twist Bioscience, up from $128.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $170.4 million in Q2 2024, with the low at $69.2 million in Q1 2021.
  • Average Operating Expenses over 5 years is $115.4 million, with a median of $119.6 million recorded in 2023.
  • The sharpest move saw Operating Expenses skyrocketed 60.71% in 2021, then dropped 25.95% in 2025.
  • Over 5 years, Operating Expenses stood at $98.0 million in 2021, then rose by 0.93% to $98.9 million in 2022, then rose by 19.83% to $118.5 million in 2023, then increased by 4.12% to $123.4 million in 2024, then grew by 10.73% to $136.6 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $136.6 million, $128.9 million, and $126.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.